Abstract:Key PointsMitochondrial DNA (mtDNA), which is well known for its role in oxidative phosphorylation and cellular energetics, is increasingly being recognized as an agonist of the innate immune system that engages various pattern-recognition receptors, including Toll-like receptors (TLRs), NOD-like receptors (NLRs) and interferon-stimulatory DNA receptors.Several features of mtDNA are potentially immunomodulatory. Unique methylation signatures and/or hypomethylation may cause mtDNA to appear more 'foreign' than 'self'. The three-stranded D-loop regulatory region or unique nucleic acid species generated during mtDNA replication and/or transcription may accumulate rapidly or resist degradation by cellular nucleases.Loss of mitochondrial membrane integrity, cellular damage or a failure to fully degrade mitochondrial constituents by autophagy can result in mtDNA-dependent triggering of endolysosomal TLR9 or cytosolic inflammasomes, such as NOD, LRR and Pyrin domain-containing protein 3 (NLRP3) and absent in melanoma 2 (AIM2), causing pro-inflammatory responses. These include cytokine and chemokine secretion (of interleukin-1β, CXC-chemokine ligand 8 and tumour necrosis factor, for example), and immune cell chemotaxis and recruitment.Intracellular mtDNA triggers type I interferon responses by engaging TLR9 or the cytosolic cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) signalling pathway. These responses culminate in the activation of interferon regulatory factors to enhance interferon secretion and interferon-stimulated gene expression. Extracellular mtDNA can also be taken up by neighbouring dendritic cells or macrophages, where it activates cGAS- or TLR9-dependent interferon expression.An ever-growing clinical and experimental literature implicates mtDNA in human inflammatory, metabolic and infectious diseases. Unravelling the mechanistic aspects of mtDNA release, sensing and resulting inflammatory pathology should have important implications for understanding the mitochondrial aetiology of human disease and ageing.

Connecting mitochondria and innate immunity

Mitochondrial Control of Innate Immune Responses

Mitochondrion: an emerging platform critical for host antiviral signaling

Mitochondria in innate immune signaling

Mitochondrial DNA release and sensing in innate immune responses

Function of Mitochondrial Antiviral Signaling Protein on the Innate Immunity

Mechanisms and Effects of Activation of Innate Immunity by Mitochondrial Nucleic Acids

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3

Mitochondrial Interactome: A Focus on Antiviral Signaling Pathways

Mitochondrial DNA in the Regulation of Innate Immune Responses

Mitochondrial DNA Release in Innate Immune Signaling

Putative Role of STING-mitochondria Associated Membrane Crosstalk in Immunity.

MAVS: A Two-Sided CARD Mediating Antiviral Innate Immune Signaling and Regulating Immune Homeostasis

Multifaceted mitochondria in innate immunity

Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity

Mitochondrial DNA in inflammation and immunity

Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses

Regulation of MAVS Expression and Signaling Function in the Antiviral Innate Immune Response

Mitochondrial DNA in innate immune responses and inflammatory pathology

Crosstalk between Dysfunctional Mitochondria and Proinflammatory Responses during Viral Infections